Sanofi loses bid to revive Lantus Solostar insulin-pen patents
![Photo: CHARLES PLATIAU/Reuters / X00217](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article13118641.ece/ALTERNATES/schema-16_9/doc7gkbrjp8ai8ivdfb8ij.jpg)
Sanofi lost its appeals court bid to revive patents on its blockbuster Lantus SoloStar insulin injection pen in a victory for drugmaker Viatris Inc.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
New Sanofi study is yet another win for blockbuster drug
For subscribers